Wegovy 2.4mg dose per click: what it means and why it matters

What the click mechanism in the 2.4mg pen actually does

The Wegovy pre-filled pen uses a spring-loaded click mechanism to advance the plunger a precise distance with each press. For the 2.4mg pen, the device is engineered so that the full weekly dose is delivered in a set number of clicks during a single injection, you press until you hear and feel the final click and the injection window turns yellow, confirming delivery. There is no dial to turn, no cartridge to fill, and no mental arithmetic about volume. The concentration of semaglutide in the 2.4mg pen and the plunger travel distance are fixed by the manufacturer, Novo Nordisk, so a full press always delivers the same amount.

If you want a side-by-side view of how each pen strength compares on volume and click count, the Wegovy dose-per-click chart lays that out clearly. The practical upshot for users: you do not control the dose per click consciously. The pen does. What you control is technique, injection angle, site rotation and holding the pen steady until the click completes.

One routine detail worth building in: most people store the pen in the fridge door between uses, which keeps it accessible without the temperature fluctuation of the freezer shelf. The exact room-temperature window for Wegovy is stated in the Patient Information Leaflet; always check that before travelling.

Why 2.4mg sits at the top of the titration ladder

Wegovy is not dispensed at 2.4mg from day one. The licensed titration pathway starts at 0.25mg weekly and steps up through 0.5mg, 1.0mg and 1.7mg before reaching 2.4mg, with roughly four weeks at each level. The lower doses exist to give your body time to adjust to semaglutide's effects on gastric emptying and appetite signalling, moving too quickly tends to intensify nausea and digestive side effects without adding meaningful clinical benefit at that stage.

By the time most people reach 2.4mg, they are typically around 16–20 weeks into treatment. The prescriber's job at each review is to confirm that the previous dose was tolerated and that weight and health markers are moving in the right direction. A dose increase is not automatic. If side effects at 1.7mg are still significant, a prescriber may hold at that level for longer before stepping up. The NHS medicines page for semaglutide describes what to expect at each stage of treatment and is a useful reference alongside your prescriber's guidance.

For context on how earlier pens in the sequence differ, the 1mg dose-per-click guide covers that step in detail, and you can read about the 0.25mg starter pen if you are at the beginning of treatment. The clinical logic is the same throughout: dose is matched to tolerance, not to a calendar.

What the 2.4mg dose decision depends on

Reaching 2.4mg is not simply a matter of completing the titration steps. Clinically, a prescriber looks at several things before approving the move to the maintenance dose: how well the current dose is tolerated, whether weight loss is progressing as expected, and whether there are any new health signals that change the picture. NICE's guidance on semaglutide (TA875) notes that continuing treatment should be reviewed if less than 5% weight loss has occurred after six months on the maintenance dose, which is one reason clinical reassessment before every repeat matters.

At nume, a GPhC-registered Independent Prescriber reviews your case before each repeat order. That review is not a formality. It is the point at which a real clinician (not an automated system) considers whether 2.4mg remains appropriate, whether any side effects need addressing, and whether the next supply should proceed. You can read more about how that process works on our Wegovy treatment page, and our clinical team's approach is set out for anyone who wants to understand the oversight behind the service.

On the cost side, private treatment pricing for Wegovy varies by dose and provider; a transparent breakdown of what is included in a private prescription service (consultation, clinical review, delivery and aftercare) is worth understanding before you compare headline figures. The weight-loss treatment overview covers the broader picture if you are still weighing up options. Wegovy is a prescription-only medicine, which means access through a legitimate, GPhC-registered pharmacy is the only lawful route, you can verify any online pharmacy at the GPhC register.

When to speak to your prescriber rather than reading on

This page answers the mechanical question about what the 2.4mg Wegovy dose per click means. It cannot answer whether 2.4mg is right for you specifically. That depends on your full health history, your current tolerance and your progress, information only a prescriber has access to after a proper clinical assessment.

If you are already on Wegovy and have questions about moving to 2.4mg, the right conversation is with your prescribing team, not a dosing FAQ. If you are considering starting Wegovy and want to understand the full titration journey, a free consultation through a regulated service is where that conversation begins. A question our prescribers hear regularly is whether it is safe to push to the next dose sooner to see faster results, the consistent clinical answer is no, and the titration schedule exists precisely to protect you from that impulse.

For a wider look at how all the Wegovy pen strengths compare, the Wegovy doses guide covers each step in the titration. And if you want to understand the dose-per-click detail across pens in one place, our dose-per-click overview is a good starting point. When you are ready to speak to someone who can actually assess your situation, our prescribers are available seven days a week.